Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2012-10-04Clinical Trial Update: Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer
A clinical trial investigating depression and interleukin-6 production in patients with ovarian epithelial cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-08-21Clinical Trial Update: Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer [Phase 2]
The Phase 2 trial of olaparib for recurrent BRCA-deficient ovarian cancer has been withdrawn (also related peritoneal and fallopian tube can…
-
CLINICAL_TRIALS withdrawal · 2012-04-19Clinical Trial Update: Cost Utility Analysis in Recurrent Ovarian Cancer
A cost-utility analysis clinical trial in recurrent ovarian cancer sponsored by MD Anderson Cancer Center has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-07-08Clinical Trial Update: Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer [Phase 1]
Phase 1 trial of capecitabine with radiation therapy for locally advanced cervical cancer or other pelvic cancers was withdrawn; sponsor Cas…
-
CLINICAL_TRIALS withdrawal · 2009-07-14Clinical Trial Update: Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens [Phase 2]
Phase 2 trial of Velcade (bortezomib) in combination with CAELYX (pegylated liposomal doxorubicin) for ovarian cancer patients who failed pl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.